Resonance Health Share Price and Company Fundamentals

0.000 (0.000%)
52 week
0.1 - 0.325

Last traded: Last Friday at 6:10 AM

Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship products include FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration; and FerriSmart, an automated software medical device to manage patients with iron overload disorders, such as thalassemia, sickle cell disease, hereditary haemochromatosis, anaemias, and cancers. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; HepaFat-AI, an artificial intelligence software tool, which is used for the automated assessment of liver fat from MRI data; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; researchers; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield



Market cap


Enterprise value


Company profile

Primary activitiesMedical Device Software
Industry / SectorMedical Devices / Healthcare
Mailing address141 Burswood Road Burswood WA 6100 Australia
Phone / Fax61 8 9286 5300 / 61 8 9286 5399


Resonance Health does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Resonance Health.

NameTitleAgeTotal Pay
Mr. Mitchell M. Wells B.Com., L.L.B., LLB, B.CommMD & Exec. Director45130k
Mr. Nick AllanCFO & Company Sec.
Chat TondutCommunications Mang.
Ms. Celine RoyetQuality Assurance & Regulatory Affairs Mang.
Dr. Jason Loveridge B.Sc., B.Sc, Ph.D., FRSMCorp. Advisor

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Resonance Health is 46.12M and its enterprise value is 37.32M. The enterprise value to revenue ratio of RHT is 9.88.

The RHT's stocks Beta value is 0.44 making it 56% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Resonance Health (RHT)

Resonance Health (ASX:RHT) Frequently Asked Questions

1. What is Resonance Health's Stock Symbol?

Resonance Health trades on ASX under the ticker symbol "RHT".

2. What is Resonance Health's stock price today?

One share of RHT stock can currently be purchased for approximately $0.1.

3. How can I contact Resonance Health?

Resonance Health's mailing address is 141 Burswood Road Burswood WA 6100 Australia. The company can be reached via phone at 61 8 9286 5300.

4. What is Resonance Health's official website?

The official website of Resonance Health is

5. Which share registry manages Resonance Health's stock?

Resonance Health's stock is managed by ADVANCED SHARE REGISTRY SERVICES.